Gil Alterovitz
Overview
Explore the profile of Gil Alterovitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
1074
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Makridis C, Mueller J, Tiffany T, Borkowski A, Zachary J, Alterovitz G
Health Policy Open
. 2024 Nov;
7:100128.
PMID: 39497918
The increasing capabilities of AI pose new risks and vulnerabilities for organizations and decision makers. Several trustworthy AI frameworks have been created by U.S. federal agencies and international organizations to...
2.
Govindan S, Spicer A, Bearce M, Schaefer R, Uhl A, Alterovitz G, et al.
Crit Care Explor
. 2024 Jul;
6(7):e1116.
PMID: 39028867
Background And Objective: To develop the COVid Veteran (COVet) score for clinical deterioration in Veterans hospitalized with COVID-19 and further validate this model in both Veteran and non-Veteran samples. No...
3.
Xie L, Wu Q, Li K, Khan M, Zhang A, Sinha B, et al.
Aging Dis
. 2024 Jun;
15(5):2168-2190.
PMID: 38916729
Alzheimer's disease (AD) is an age-dependent neurodegenerative disease characterized by extracellular Amyloid Aβ peptide (Aβ) deposition and intracellular Tau protein aggregation. Glia, especially microglia and astrocytes are core participants during...
4.
Murcia V, Aggarwal V, Pesaladinne N, Thammineni R, Do N, Alterovitz G, et al.
AMIA Jt Summits Transl Sci Proc
. 2024 Jun;
2024:125-134.
PMID: 38827083
Clinical trials are critical to many medical advances; however, recruiting patients remains a persistent obstacle. Automated clinical trial matching could expedite recruitment across all trial phases. We detail our initial...
5.
Clark M, Meyer C, Ramos-Cejudo J, Elbers D, Pierce-Murray K, Fricks R, et al.
Stud Health Technol Inform
. 2024 Jan;
310:735-739.
PMID: 38269906
High-resolution whole slide image scans of histopathology slides have been widely used in recent years for prediction in cancer. However, in some cases, clinical informatics practitioners may only have access...
6.
Zhang X, Peng B, Zhang S, Wang J, Yuan X, Peled S, et al.
J Pineal Res
. 2023 Nov;
76(1):e12925.
PMID: 37986632
Stroke is the leading cause of death and disability worldwide. Novel and effective therapies for ischemic stroke are urgently needed. Here, we report that melatonin receptor 1A (MT1) agonist ramelteon...
7.
Wu J, Shenoy E, Carey E, Alterovitz G, Kim M, Branch-Elliman W
Infect Control Hosp Epidemiol
. 2023 Nov;
45(1):9-10.
PMID: 37946379
No abstract available.
8.
Lezama J, Alterovitz G, Jakey C, Kraus A, Kim M, Borkowski A
Front Artif Intell
. 2023 Aug;
6:1191320.
PMID: 37601037
In order to address a long standing challenge for internal medicine physicians we developed artificial intelligence (AI) models to identify patients at risk of increased mortality. After querying 2,425 records...
9.
Tong Y, Zhang J, Sun N, Wang X, Wei Q, Zhang Y, et al.
Sci Bull (Beijing)
. 2023 Jan;
66(18):1895-1905.
PMID: 36654399
Clinical use of antimicrobials faces great challenges from the emergence of multidrug-resistant pathogens. The overexpression of drug efflux pumps is one of the major contributors to multidrug resistance (MDR). Reversing...
10.
Makridis C, Kelly J, Alterovitz G
PLoS One
. 2022 Dec;
17(12):e0269588.
PMID: 36548244
Do medical facilities also help advance improvements in socio-economic outcomes? We focus on Veterans, a vulnerable group over the COVID-19 pandemic who have access to a comprehensive healthcare network, and...